ADMA Biologics Inc (NASDAQ:ADMA)

1.38
Delayed Data
As of Dec 08
 +0.015 / +1.10%
Today’s Change
1.01
Today|||52-Week Range
3.11
-29.49%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for ADMA Biologics Inc have a median target of 5.00, with a high estimate of 10.00 and a low estimate of 3.00. The median estimate represents a +263.64% increase from the last price of 1.38.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in ADMA Biologics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.10
Sales
$22.0M
Reporting Date
Mar 24

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 21.54%
 
 
 
 
 
 
Growthannually 39.77%
 
 
 
 
 
 

Sales

Growthquarterly 6.59%
 
 
 
 
 
 
Growthannually 79.86%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.